Exchange: NYSE·Updated 07:34 PM EDT
WST logo

WSTWest Pharmaceutical Services, Inc.

$359.24
$6.92
(1.96%)
Today
Closed $359.24
$0.00
(0.00%)
After Hours
EarningsJul 23
Mkt Cap$24.89B
Vol752,720.00
News
all
press releases
West Declares Quarterly Dividend
West Declares Quarterly Dividend West Declares Quarterly Dividend PR Newswire EXTON, Pa., July 21, 2026 EXTON, Pa., July 21, 2026 /PRNewswire/ -- OnJuly 21, 2026, the Board of Directors ofWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug...
PR Newswire
More News
WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?
WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.
Zacks
Omnicell to Report Q2 Earnings: OmniSphere in Focus
OMCL heads into Q2 earnings with OmniSphere adoption, Connected Devices execution and recurring revenue growth ahead of July 30 results.
Zacks
GEHC Launches MIM Anyware for Secure Remote Imaging Collaboration
GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.
Zacks
Stock Market News for July 21, 2026
Wall Street closed lower on Monday, pulled down by healthcare and industrial stocks.
Zacks
Curious about West Pharmaceutical (WST) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for West Pharmaceutical (WST), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Zacks
MMSI vs. WST: Which Stock Should Value Investors Buy Now?
MMSI vs. WST: Which Stock Is the Better Value Option?
Zacks
Align Technology to Report Q2 Earnings: Clear Aligner Segment in Focus
ALGN reports Q2 results on July 29, with investors watching Clear Aligner growth as higher volumes and digital offerings shape quarterly performance.
Zacks
Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S.
BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother handling, one-handed use and surgical flexibility.
Zacks
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth
ISRG beats second-quarter earnings and revenue estimates, but shares fall after hours as procedure growth slows sequentially despite strong placements.
Zacks
<
1
2
...
>

Advertisement|Remove ads.